Health care providers can administer vaccines “off-label”, but insurance coverage is widely based on FDA recommendations. The new, narrower FDA approval will likely reduce both access to COVID ...

The Food and Drug ... COVID-19 vaccines that will likely narrow recommendations for the vaccines to people over 65 and those at high risk for severe outcomes—a switch that could limit access ...

The U.S. Food and Drug Administration is changing its policy on who should get COVID-19 shots, potentially limiting access to new vaccine formulations ... lower age limits in other countries ...

FDA officials said the new approval process ... “This approach would limit access to updated vaccines for millions of Americans who still wish to reduce their risk of disease, even if their ...

Taking away vaccines from people who might benefit: not so much. This week, two new leaders at the US Food and Drug Administration announced plans to limit access to covid vaccines, arguing that ...

Top officials for the Food and Drug Administration laid out new requirements for access to yearly COVID ... lengthy studies before tweaked vaccines can be approved for healthier people.

The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna's existing vaccine. It found the new vaccine was safe and was at least as ...

Updated COVID-19 vaccines are now required to undergo placebo-controlled clinical trials prior to approval, which could limit access to shots ... at the Food and Drug Administration (FDA) stated ...

Despite the fact that vaccines against COVID have already undergone strict safety reviews and that people continue to die from the disease, Trump’s FDA is moving to reduce access to annual COVID boost ...

Rock Obst , CC BY-SA Additionally, FDA officials point to Canada, Australia and some European countries that limit ... vaccine experts have expressed concerns that limiting COVID-19 vaccine access ...

Top officials for the Food and Drug Administration laid out new requirements for access to ... s approach will limit options for parents and their children. “If the vaccine were no longer ...

The FDA is moving to risk-based access for COVID-19 vaccines. The New England Journal of Medicine article includes a lengthy list of conditions that increase the risk of severe COVID-19 and notes ...